Apollo Hospitals Enterprise Ltd on Tuesday (March 4) said it plans to set up a comprehensive oncology centre featuring India’s first Proteus One proton system by investing ₹250 crore over the next three years. The new facility will be located in Hyderabad and is expected to be operational by FY2028.
The project aims to expand Apollo’s existing proton therapy capacity, which currently treats over 500 patients annually at its Chennai centre, designed for 850 patients. The new addition will enable treatment for 350 more patients annually. The investment will be funded through internal accruals.
Apollo Hospitals has partnered with Ion Beam Applications (IBA), a global leader in proton beam therapy solutions, to bring the Proteus One system to India. Apollo first introduced proton therapy in 2019 at its Chennai centre, making it the only facility in South Asia and the Middle East.
Also Read: Apollo Hospitals to add 3,000 beds at an investment of ₹6,000 crore in next 3 years: Sangita Reddy
The advanced treatment is used for complex cancers, including central nervous system, head and neck tumours, paediatric, and urological cancers.
Dr Prathap C Reddy, Founder-Chairman, Apollo Hospitals Enterprise Ltd, said, “The addition of Proteus One to our Apollo Proton Cancer Centres further solidifies our position as a global leader in proton therapy. This next-generation technology will allow us to achieve superior clinical outcomes and significantly improve the quality of life for cancer patients in India and beyond.”
Shares of Apollo Hospitals Enterprise Ltd ended at ₹6,183.45, up by ₹6.30, or 0.10%, on the BSE.
Also Read: Apollo Hospitals Q3 profit surges 49% on-year; declares interim dividend
